Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The version history now includes a new entry 'Revision: v3.3.3'. Entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:25:45.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a new version on 2025-12-04 updating the Study Status and Contacts/Locations; the 2025-11-04 entry was removed.
    Difference
    0.3%
    Check dated 2025-12-09T01:25:40.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added to the history and the previous revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:55:23.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page removed the government funding status notice. This change does not affect the study data, status, or records displayed on the page.
    Difference
    0.4%
    Check dated 2025-11-17T20:04:40.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new Study Status entry (version 61) was added on 2025-11-04 reflecting status updates from 2025-11-02, and an earlier entry from 2025-10-06 was removed.
    Difference
    0.2%
    Check dated 2025-11-10T17:23:52.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The new screenshot shows updated entries in the Record History, with multiple updates to Study Status and Contacts/Locations for NCT04603807. These updates indicate ongoing maintenance of recruitment status and trial details.
    Difference
    0.1%
    Check dated 2025-11-03T13:47:04.000Z thumbnail image

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.